Vivani Medical: Strategic Innovation in GLP-1 Obesity Treatment Justifies Buy Rating

TipRanksDec 22, 2024 18:15 · Ratings

H.C. Wainwright Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $3

Futu NewsDec 21, 2024 03:31 · Ratings

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)

TipRanksDec 21, 2024 02:41 · Ratings

Express News | Vivani Medical Inc: Anticipates That Top-Line Data Will Be Available in Mid-2025

BreakingsDec 19, 2024 21:30

EXCLUSIVE: Vivani Medical Tells Benzinga 'Study Represents the First Clinical Application of NanoPortal, the Company's Proprietary Drug Implant Platform Technology'

BenzingaDec 19, 2024 21:00

EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia

BenzingaDec 19, 2024 21:00